Rajan Sharma
Stock Analyst at Goldman Sachs
(0.26)
# 4,308
Out of 4,996 analysts
5
Total ratings
25%
Success rate
-12.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $9.16 | -20.85% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $73.76 | +31.51% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $39.85 | +17.94% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $34.02 | +132.22% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $9.16
Upside: -20.85%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $73.76
Upside: +31.51%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $39.85
Upside: +17.94%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $34.02
Upside: +132.22%